News and Trends 23 Nov 2016
These Biotech Veterans have Launched a Startup to ‘Drug the Undruggable’
GPCRs have spelled “dead end” for many a biotech and academic endeavor. I sat down with Confo Therapeutics to hear about how they’re recruiting antibodies for a new onslaught. Despite their allure as the key to many indications, GPCRs are not a target for the faint of heart because they tend to move through a […]